Diabetic foot ulceris a major complication ofdiabetesmellitus, and probably the major component of thediabetic foot. Diabetic foot ulcers are among one of the major global medical issues. Management of diabetic foot ulcers aims at fast healing and wound closure, by adopting a multidisciplinary therapeutic approach so as to avoid amputation.
Diabetic Foot Ulcer Therapeutic Market contains market size and forecasts of Diabetic Foot Ulcer (DFU) Therapeutic in Global, including the following market information:
- Global Diabetic Foot Ulcer (DFU) Therapeutic Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global top five companies in 2021 (%)
The global Diabetic Foot Ulcer (DFU) Therapeutic market was valued at 4743.5 million in 2021 and is projected to reach US$ 7141.6 million by 2028, at a CAGR of 6.0% during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Wound Care Dressing Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Diabetic Foot Ulcer (DFU) Therapeutic include 3M, Smith & Nephew, Molnlycke Health Care, ConvaTec, Coloplast, Integra LifeSciences, Essity (BSN Medical), Medline and B. Braun and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Diabetic Foot Ulcer (DFU) Therapeutic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diabetic Foot Ulcer (DFU) Therapeutic Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Diabetic Foot Ulcer (DFU) Therapeutic Market Segment Percentages, by Type, 2021 (%)
- Wound Care Dressing
- Biologics
- Therapy Devices
- Antibiotic Medications
- Others
Global Diabetic Foot Ulcer (DFU) Therapeutic Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Diabetic Foot Ulcer (DFU) Therapeutic Market Segment Percentages, by Application, 2021 (%)
- Neuropathic Ulcers
- Ischemic Ulcers
- Neuro-ischemic Ulcers
Global Diabetic Foot Ulcer (DFU) Therapeutic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Diabetic Foot Ulcer (DFU) Therapeutic Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Diabetic Foot Ulcer (DFU) Therapeutic revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Diabetic Foot Ulcer (DFU) Therapeutic revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- 3M
- Smith & Nephew
- Molnlycke Health Care
- ConvaTec
- Coloplast
- Integra LifeSciences
- Essity (BSN Medical)
- Medline
- B. Braun
- Organogenesis
Industry Market Size
